Advances in Myeloma Treatments: What Patients & Caregivers Need to Know

preview_player
Показать описание
This webinar focuses on “Advances in Myeloma Treatments: What Patients & Caregivers Need to Know.” IMF Chairman Dr. Brian G.M. Durie moderated presentations with IMF Nurse Leadership Board Member Teresa Miceli RN, BSN, OCN (Mayo Clinic — Rochester, MN); Adam Cohen, MD (University of Pennsylvania Perelman School of Medicine — Philadelphia); Paul Richardson, MD (Dana-Farber Cancer Institute — Boston); and IMF Vice President of Support Groups Robin Tuohy. Attendees learned what the latest advancements in myeloma research mean for patients, how to better manage side effects, optimal choices for relapsed patients, and more.

Speakers and Topics:

00:00 - Welcome
Brian G.M. Durie, MD

04:31 - Myeloma 101 & Advances in Myeloma Treatments: Looking Beyond 2021
Brian G.M. Durie, MD

24:20 - Life Is A Canvas, You Are The Artist: Side effects & symptom management
Teresa Miceli, RN, BSN, OCN

1:22:32 - Immune Therapies: Treatments That Work With Our Own Immune Systems
Dr. Adam Cohen

1:52:36 - How to Find What You Need to Know
Robin Tuohy

2:10:42 - When Myeloma Comes Back: Approaches to Relapse
Dr. Paul Richardson

_______________
Improving Lives | Finding the Cure

In the United States, an estimated 32,270 new multiple myeloma cases will be diagnosed in 2021. 159,985 new myeloma cases are diagnosed yearly.

Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.

Find us online:

Category
Nonprofits & Activism
License
Standard YouTube License

In most cases, captions are autogenerated by YouTube.
Рекомендации по теме
Комментарии
Автор

Thank you doctors and nurses on the panel.

phoarey
Автор

So incredibly informative . . . I began RVD + DARA Today . . . so excited!

lynnargain
Автор

My mom is a new diagnosed multiple myeloma patient light chain myeloma to be exact. She was diagnosed on the 14th and no one from the oncology team has told the family anything.

She had a hip replacement Fri I'm watching her hemoglobin number steady going down and this morning she had a blood transfusion. She's 66 very healthy outside of this and I'm terrified that the doctors aren't doing their job well.

She has acute kidney damage her B2M was checked on the 17th and it was a 4.33 and LDH is normal her creatinine is 1.09 hemoglobin 6.4 can someone please help me understand anything 🙏🏽

willthompson
Автор

You should not be "boosting" already immuno-compromised patients every 6 months until studies come out showing that is a safe and effective method for the variant in question. The current vaccine and booster is for the Alpha variant. At the time of this video the Delta strand is the main variant and of course after that the Omicron variant. Scientists should follow the science not by mere conjecture but by actual relevant scientific data.

JR-fcqp
Автор

😞😞 I'm scared... I'm absolutely terrified.

lulubelle